Otavio Berwanger to Male
This is a "connection" page, showing publications Otavio Berwanger has written about Male.
Connection Strength
0.132
-
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021 09; 9(9):586-594.
Score: 0.013
-
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial. JAMA Cardiol. 2018 05 01; 3(5):391-399.
Score: 0.010
-
Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial. JAMA. 2018 04 03; 319(13):1331-1340.
Score: 0.010
-
Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial. Am Heart J. 2018 08; 202:89-96.
Score: 0.010
-
Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial. Am Heart J. 2018 04; 198:129-134.
Score: 0.010
-
Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation. 2018 03 13; 137(11):1132-1142.
Score: 0.010
-
A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial. Trials. 2011 Feb 24; 12:53.
Score: 0.006
-
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 07 29; 385(5):406-415.
Score: 0.003
-
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. 2021 06 12; 397(10291):2253-2263.
Score: 0.003
-
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021 01 20; 372:n84.
Score: 0.003
-
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1307-1316.
Score: 0.003
-
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet. 2020 10 03; 396(10256):959-967.
Score: 0.003
-
Epidemiologic and clinical features of patients with COVID-19 in Brazil. Einstein (Sao Paulo). 2020; 18:eAO6022.
Score: 0.003
-
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. 2020 11 19; 383(21):2041-2052.
Score: 0.003
-
Improving Hypertension Outcome Measurement in Low- and Middle-Income Countries. Hypertension. 2019 05; 73(5):990-997.
Score: 0.003
-
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. N Engl J Med. 2019 04 18; 380(16):1509-1524.
Score: 0.003
-
Effects of Bariatric Surgery Versus Medical Therapy on the 24-Hour Ambulatory Blood Pressure and the Prevalence of Resistant Hypertension. Hypertension. 2019 03; 73(3):571-577.
Score: 0.003
-
Myocardial Injury After Noncardiac Surgery (MINS) in Vascular Surgical Patients: A Prospective Observational Cohort Study. Ann Surg. 2018 08; 268(2):357-363.
Score: 0.003
-
Troponin T monitoring to detect myocardial injury after noncardiac surgery: a cost-consequence analysis. Can J Surg. 2018 06; 61(3):185-194.
Score: 0.003
-
Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension: a randomized clinical trial. J Hypertens. 2018 04; 36(4):933-938.
Score: 0.003
-
Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE). Can J Cardiol. 2018 03; 34(3):295-302.
Score: 0.003
-
Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial. Trials. 2017 Dec 19; 18(1):601.
Score: 0.003
-
Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2017 10 10; 318(14):1335-1345.
Score: 0.002
-
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet. 2017 Oct 14; 390(10104):1737-1746.
Score: 0.002
-
Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF). Am Heart J. 2017 Oct; 192:38-47.
Score: 0.002
-
Predictors, Prognosis, and Management of New Clinically Important Atrial Fibrillation After Noncardiac Surgery: A Prospective Cohort Study. Anesth Analg. 2017 07; 125(1):162-169.
Score: 0.002
-
Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. JAMA. 2017 Apr 25; 317(16):1642-1651.
Score: 0.002
-
Diabetes and cardiovascular events in high-risk patients: Insights from a multicenter registry in a middle-income country. Diabetes Res Clin Pract. 2017 May; 127:275-284.
Score: 0.002
-
Effects of gastric bypass surgery in patients with hypertension: rationale and design for a randomised controlled trial (GATEWAY study). BMJ Open. 2014 Sep 08; 4(9):e005702.
Score: 0.002
-
Femoral versus radial access in primary angioplasty. Analysis of the ACCEPT registry. Arq Bras Cardiol. 2014 Jun; 102(6):566-70.
Score: 0.002